Key result
Low miR-140-3p during acute heart failure hospitalization is linked to increased long-term all-cause mortality.
Why the study?
Do low levels of mitochondrial dynamics-related miRNAs (miR-140-3p) during AHF treatment predict an increased risk of long-term adverse outcomes in patients with acute heart failure?
Cohort (n=234)
Do low levels of mitochondrial dynamics-related miRNAs (miR-140-3p) during AHF treatment predict an increased risk of long-term adverse outcomes in patients with acute heart failure?
Answers are grounded in this paper and cite their sources.
Low levels of mitochondrial fission-related miRNAs (miR-140-3p) during acute heart failure treatment are independently associated with an increased risk of long-term mortality and heart failure events.
Mitochondrial dynamics-related RNAs during hospitalization for acute heart failure (AHF) were rarely evaluated in various points. In total, 234 patients who visited the emergency room for AHF were retrospectively evaluated. Blood samples were collected within 15 min of admission (day 1), after 48-72 h, and between days 7 and 21. Low miR-140-3p during hospitalization was defined as the level being categorized as Q1 more than once (on days 1, 3 and/or 14), and normal-140-3p during hospitalization as the level never being categorized as Q1. The median miR-140-3p levels were significantly decreased on days 3 and 14 (2.53 [1.06-6.42] and 3.65 [1.41-9.05], respectively) in comparison to the value on day 1 (6.71 [2.66-14.0]). Kaplan-Meier curves indicated that all-cause mortality within 1000 days was significantly higher in the low-miR-140-3p group than in the other-miR-140-3p group on days 1 and 14. Moreover, the survival rate was significantly lower and the rate of HF events was significantly higher in the low-miR-140-3p group than in the normal-miR-140-3p group. The miRNA levels of patients further decreased during treatment for AHF. Low levels of mitochondrial fission-related miRNAs during AHF treatment were independently associated with an increased risk of long-term adverse outcomes.
No takes yet. Share an insight, caveat, or question.
Shirakabe et al. (2025) conducted a cohort in Acute heart failure (n=234). Low miR-140-3p levels vs. Normal miR-140-3p levels was evaluated on All-cause mortality within 1000 days. Low miR-140-3p levels during acute heart failure hospitalization were significantly associated with higher all-cause mortality within 1000 days and increased heart failure events.
Synapse has enriched 10 related papers. Consider them for comparative context: